4Wendt T,Tanji N,Guo J,et al.Glucose,glycation,and RAGE:implications for amplification of cellular dysfunction in diabetic nephropathy.J Am Soc Nephrol,2003,14(5):1383-1395.
5Wendt TM,Tanji N,Guo J,et al.RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.Am J Pathol,2003,162(4):1123-1137.
6Kislinger T,Tanji N,Wendt T,et al.Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.Arterioascler Thromb Vasc Bioi,2001,21 (6):905-910.
7Pan HZ,Zhang L,Guo MY,et al.The oxidative stress states in diabetes mellitus and diabetic nephropathy.Acta Diabetol,2009.28.
8Wang N,Fan Y,Ni P,et al.High glucose effect on the role of CD146 in human proximal tubular epithelial cells in vitro.J Nephrol,2008,21 (6):931-940.
3Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and the their ligands. Physiol Rev,1999,79:81-213.
4Geoffrey SK. Selectins and their ligands: current concepts and controversies. Blood,1996,88:3259-3287.
5Ruchaud Sparagao MH, Malaud E, Gayet O, et al. Mapping the epitope of a functional P-selectin monoclonal antibody (LYP20) to a short completment-like repeat (SCR 4) domain: use of human-mouse chimaera and homologue-replacement mutagenesis. Biochem J,1998,332:309-314.
6McEver RP, Cummings RD. Role of PSGL-1 binding to seleetins in leukocyte recruitment. J Clin Invest,1997,100(11 suppl):s97-103.
7Zhou T,Song W,Wang F,et al. Cloning,expression of the Lectin-EGF domain of P-selectin and preparation of its monoclonal antibody. Acta biochimica et biophysica sinica,2003,35:172-176.
9Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.Diabetes,2001,50:2384-2389.
10Weyer C, Yudkin JS, Stehouwer CD, et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis,2002,161:233-242.
